Pharmaceutical brand, payer marketing, market access, and managed markets teams—is senior management confident in your health system/integrated delivery network (IDN) strategy and performance?
Now that you’ve concluded your brand’s 2020 business plans and finalized budgets, did senior management express confidence in your health system/integrated delivery network (IDN) strategy and performance?
Cancer treatment has been transformed by therapeutic innovation based on improved understanding of disease biology and advances in precision medicine and immuno-oncology. This exciting time of advancement has achieved unprecedented improvements in survival and reduced side-effects compared to chemotherapy but also introduced skyrocketing cost challenges.
Branded pharmaceutical market access may seem challenging in long-term care (LTC) if you only consider the higher drug cost without factoring in the potential total cost of care offset associated with an evidenced-based therapeutic option.
Discover what good looks like in a Pharma-IDN EHR collaboration and how to ensure your key account management team has everything they need for success.